Project Goals:

Building a screening program for the needy population in Israel, who do not reach eye clinics due to lack of accessibility.
Construction of a mobile eye clinic project to perform examinations in the community, day care centers, community centers, nursing homes, assisted living, etc.
Identifying diseases that cause blindness among a population that does not have access to medical services in Israel and accompanying the mobile clinic project in an evaluation study.

 

Project purposes:

  • Reducing the number of patients by at least 10% in the three diseases that cause blindness:
  • Approximately 200,000 patients with age-related macular degeneration.
  • Approximately 160,000 patients with diabetic retinopathy.
  • Approximately 130,000 patients with glaucoma.
  • 20% of children under the age of 6 need treatment from a pediatric ophthalmologist.


Target audience and project operation details:

The mobile clinic project reaches thousands of people in need per year, most of them over the age of 55+. The underprivileged and disabled, with an emphasis on immigrants From the Soviet Union and Ethiopia, a population of minorities and recipients of National Insurance benefits, some of whom are Saudi patients.

 

Mobile eye examination:

An innovative and unique project throughout the country, for eye examinations of the elderly who do not come to the health fund clinics.
A mobile equipped with the best medical equipment, in which an optometrist and an ophthalmologist come and examine the elderly in the community, in order to diagnose diseases that cause blindness.

 

Mobile project operation team:

Medical team: Senior specialist doctors from all hospitals in the country and volunteer optometrists.
On the mobile team: An ophthalmologist specializing in examinations and interpretation of retinal photographs, an optometrist for vision testing and a driver.
On the project operation team: A project manager and volunteer coordinators.

 

Mobile project partners:

A donation to the mobile eye examination was made as an independent donation, without involvement in the content, by the company Roche.

 

Project results in 2025 (project in existence since 2013):

 

20260217110336212.png